hypertension

(redirected from drug-resistant hypertension)
Also found in: Thesaurus, Medical, Encyclopedia.

hy·per·ten·sion

 (hī′pər-tĕn′shən)
n.
1.
a. Abnormally elevated arterial blood pressure.
b. Arterial disease marked by chronic high blood pressure.
2. Elevated pressure or tension of a body fluid, as of the intraocular or cerebrospinal fluids.

hypertension

(ˌhaɪpəˈtɛnʃən)
n
(Pathology) pathol abnormally high blood pressure
hypertensive adj, n

hy•per•ten•sion

(ˌhaɪ pərˈtɛn ʃən)

n.
1.
a. elevation of the blood pressure, esp. the diastolic pressure.
b. an arterial disease characterized by this condition.
2. excessive nervous tension.
[1890–95]

hy·per·ten·sion

(hī′pər-tĕn′shən)

hypertension

High blood pressure, often caused by stress, arteriosclerosis, or heart disease.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hypertension - a common disorder in which blood pressure remains abnormally high (a reading of 140/90 mm Hg or greater)hypertension - a common disorder in which blood pressure remains abnormally high (a reading of 140/90 mm Hg or greater)
cardiovascular disease - a disease of the heart or blood vessels
essential hypertension, hyperpiesia, hyperpiesis - persistent and pathological high blood pressure for which no specific cause can be found
malignant hypertension - severe hypertension that runs a rapid course and damages the inner linings of the blood vessels and the heart and spleen and kidneys and brain; "malignant hypertension is the most lethal form of hypertension"
secondary hypertension - hypertension that is secondary to another disease
white-coat hypertension - temporary rise in blood pressure in the doctor's office
hypotension - abnormally low blood pressure
Translations
hypertenze

hypertension

[ˈhaɪpəˈtenʃən] N (Med) → hipertensión f

hypertension

[ˌhaɪpərˈtɛnʃən] nhypertension f

hypertension

[ˌhaɪpəˈtɛnʃn] n (Med) → ipertensione f

hy·per·ten·sion

n. hipertensión, presión arterial alta;
benign ______ benigna;
essential ______ esencial;
malignant ______ maligna;
portal ______ portal;
primary ______ primaria;
renal ______ renal.

hypertension

n hipertensión f, presión alta (de la sangre) (fam); benign intracranial — hipertensión intracraneal benigna; essential — hipertensión esencial; malignant — hipertensión maligna; portal — hipertensión portal; pulmonary — hipertensión pulmonar; renovascular — hipertensión renovascular; white-coat — hipertensión de bata blanca
References in periodicals archive ?
CBSET focuses on critically important therapeutic fields such as interventional cardiology, renal disease and dialysis, chronic drug-resistant hypertension, women's health, minimally invasive surgery, orthopedics, biological and synthetic tissue repair, drug delivery, bioresorbable devices and combination medical device and drug-eluting products.
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, doubleblind, crossover trial.
The incessantly rising obese population and the increasing prevalence of co morbidities related with sleep apnea (such as drug-resistant hypertension, congestive heart failure, Type-2 diabetes, and stroke, among others) are helping the total patient pool of sleep apnea to rise in the future as well.
CBSET, Concord Biomedical Sciences & Emerging Technologies, is the preclinical research leader in critically important therapeutic fields such as interventional cardiology, renal disease and dialysis, chronic drug-resistant hypertension, women's health, minimally invasive surgery, orthopedics, biological and synthetic tissue repair, drug delivery, bioresorbable devices, and combination medical device and drug-eluting products.
Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years.
Due to incessantly rising obesity rates and the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, stroke, etc.
It is said that Renal denervation is a catheter-based ablation procedure used for treating patients with drug-resistant hypertension.
One important study documented, the overall prevalence of OSA (defined as more than 10 events per hour) to be 83% among persons with drug-resistant hypertension, including 96% among men and 65% among women.
Data suggest that OSA is present in about 80% of individuals with drug-resistant hypertension (35% of all hypertension) and in 50% of those with atrial fibrillation.
In 2015, the National Health Service estimated that about 500,000 people in the UK had drug-resistant hypertension.